Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | CA9 | Q16790 | 1/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 14/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.52 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29398543 | 0.99 | CA1 (0.60) | CA1CA2CA12CA9PTGS2 | |
| SCHEMBL30423958 | 0.89 | CYP11B1 (0.59) | CA1CA2CA12CA9PTGS2 | |
| Hydrochloric Acid SCHEMBL29396259 | 0.88 | CYP11B1 (0.57) | CA1CA2CA12CA9PTGS2 | |
| SCHEMBL30425393 | 0.86 | CA1 (0.64) | CA1CA2CA12CA9PTGS2 | |
| SCHEMBL29396714 | 0.80 | CA1 (0.76) | CA1CA2CA12CA9PTGS2 | |
| SCHEMBL10175126 | 0.80 | CA12 (0.53) | CA1CA2CA12CA9PTGS2 | |
| SCHEMBL17896717 | 0.79 | MEN1 (0.62) | CA1CA2CA12CA9CYP11B1 | |
| SCHEMBL18229491 | 0.78 | HDAC6 (0.73) | CA1CA2CA12CA9 | |
| SCHEMBL29399712 | 0.75 | PTGS2 (0.51) | CA1CA2CA12CA9PTGS2 | |
| SCHEMBL30663908 | 0.74 | ALDH1A1 (0.56) | CA1CA2CA12CA9CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116075510-A | 1H-benzo [ d ] imidazole derivatives as TLR9 inhibitors for the treatment of fibrosis | 百时美施贵宝公司 | 2023-05-05 | — | — | CN | claimed |
| EP-4200292-A1 | 1H-BENZO[D]IMIDAZOLE DERIVATIVES AS TLR9 INHIBITORS FOR THE TREATMENT OF FIBROSIS | Bristol-Myers Squibb Company (US) | 2023-06-28 | — | — | EP | disclosed |
| CN-116075510-A | 1H-benzo [ d ] imidazole derivatives as TLR9 inhibitors for the treatment of fibrosis | 百时美施贵宝公司 | 2023-05-05 | — | — | CN | disclosed |
| WO-2022040260-A1 | 1H-BENZO[D]IMIDAZOLE DERIVATIVES AS TLR9 INHIBITORS FOR THE TREATMENT OF FIBROSIS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2022-02-24 | — | — | WO | disclosed |